MIV Therapeutics Inc (MIVI) - Product Pipeline Analysis by GlobalData

VIEWS: 21 PAGES: 22

More Info
									                                  MIV Therapeutics Inc (MIVI) - Product Pipeline Analysis

     Reference Code: GDMEPH82129PD                                                                                            Publication Date: NOV 2010



     Company Snapshot                                                            Company Overview
     Key Information
                                                                                 MIV Therapeutics Inc. (MIVT) is an advanced stage, research and
      MIV Therapeutics Inc, Key Facts                                            development company, that is engaged in the development of
                                                                                 biocompatible coatings for stents and other medical devices and
      Web Address                           www.mivtherapeutics.com
                                                                                 advanced drug delivery systems. MIVT is focused in providing healing
      Turnover           (in        USD 1.10                                     solutions for cardiovascular disease and other medical conditions. The
      Million)                                                                   companies hydroxyapatite (“HAp”) based product the VESTAsync
                                                                                 coronary drug eluting stent system is in animal studies and human
      Number of Employees                   115                                  clinical trials. Through its collaborative research agreement with The
      Industry                              Pharmaceuticals and Healthcare       University of British Columbia MIVT has developed coating technologies
      Source:Primary / Secondary Research                                        that utilize HAp for application on drug delivery systems and medical
      GlobalData                                                                 devices.



     MIV Therapeutics Inc Pipeline Products

      MIV Therapeutics Inc Key Pipeline Products by Equipment                    MIV Therapeutics Inc Key Pipeline Products by Therapy Area
      Type
     Equipment Type                               No of Products                 Therapy Area                                           No of Products
     Interventional Cardiology                                3                  Atherosclerosis                                                    3
     Peripheral Vascular Devices                              1                  Cardioembolic stroke                                                 1
     Source: Primary / Secondary Research                                        Source: Primary / Secondary Research
     GlobalData                                                                  GlobalData


     MIV Therapeutics Inc Key Pipeline Products by Equipment Type




      Source: Primary / Secondary Research
      GlobalData




     MIV Therapeutics Inc Key Pipeline Products by                               MIV Therapeutics Inc Key Pipeline Products by Trial Phase
     Development Stage
     Developmental Stage                         No of Products                  Trial Phase                                            No of Products
     Clinicals                                               3                   Phase IV                                           -
     Pre-Clinicals                                                               Phase III                                          -
                                                 -
     Early development                                                       1   Phase II                                           -
     Source: Primary / Secondary Research                                        Phase I                                                              1
     GlobalData
                                                                                 Source: Primary / Secondary Research
     Note : (-) indicates 'Not Available'
                                                                                 GlobalData
                                                                                 Note : (-) indicates 'Not Available'




MIV Therapeutics Inc (MIVI) - Product Pipeline Analysis                                                                        Reference Code: GDMEPH82129PD

Source : www.globalcompanyintelligence.com                                                                                                                 Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 3
     Key Facts ............................................................................................................................................................................................................................................................................... 4
     MIV Therapeutics Inc - Major Products and Services ............................................................................................................................................................................................................ 5
           MIV Therapeutics Inc Pipeline Products by Equipment Type.......................................................................................................................................................................................... 6
           MIV Therapeutics Inc Pipeline Products by Development Stage .................................................................................................................................................................................... 8
           MIV Therapeutics Inc Pipeline Products by Therapy Area ............................................................................................................................................................................................ 10
           MIV Therapeutics Inc Pipeline Products by Trial Phase................................................................................................................................................................................................ 12
           AEPD II-Dual purpose Device ....................................................................................................................................................................................................................................... 14
                 Product Status......................................................................................................................................................................................................................................................... 14
                 Product Description ................................................................................................................................................................................................................................................. 14
           Protea ultra-thin cobalt-alloy bare metal stent ............................................................................................................................................................................................................... 14
                 Product Status......................................................................................................................................................................................................................................................... 14
                 Product Description ................................................................................................................................................................................................................................................. 14
                 Product Milestone ................................................................................................................................................................................................................................................... 14
           Vestapor .................................................................................................................................................................................................
								
To top